Bis-heteroaryl amide compounds and uses thereof
TW202641513APending Publication Date: 2026-10-16XENON PHARMACEUTICALS INC
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- TW114150247
- Authority / Receiving Office
- TW · TW
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2025-06-30
- Filing Date
- 2025-12-19
- Publication Date
- 2026-10-16
Abstract
Provided herein are compounds, including compounds of any of the formulae described herein (e.g., Formula (I)), and pharmaceutically acceptable salts, stereoisomers, tautomers, solvates, hydrates, isotopically labeled derivatives, and prodrugs thereof. Compounds provided herein can potentiate Kv7 potassium channels (e.g., Kv7.2 / Kv7.3). In some embodiments, the compounds provided herein are useful in the treatment and / or prevention of diseases, disorders, and conditions (e.g., diseases, disorders, and conditions associated with Kv7 potassium channel dysfunction). In some embodiments, the compounds provided herein target Kv7 voltage-sensing domains (VSDs).
Need to check novelty before this filing date? Find Prior Art
